chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It is a spontaneous report to the VAERS program concerning a child patient with unknown gender and age. The patient's medical history, concurrent diseases, and concomitant medications were not reported. On an unknown date, the patient received nasal FLUMIST. Two days after vaccination, the patient had a seizure, and the patient died. The cause of death was seizure. Interval after vaccination unknown. According to the reporter the seizure was considered to be serious with the serious criteria of death.
Herpes zoster on right side; shortness of breath after vaccination. Seen in office 2/9/21. Chest x-ray completed, patient prescribed valacyclovir, prednisone, tramadol. Patient reports improved breathing and pain 2/10/2021 since beginning treatments
mild numbness & tingling hand 15mins p/vax;sx persisted for 1/2 of day & resolved;
UNTIL NOW ITS SO TIGHT; EVERY TIME PUT HANDS UP DON'T HAVE STRENGTH, VERY WEAK; AFTER I HAVE VACCINE IN THAT SPOT THE PAIN IS THERE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 2021, the patient experienced until now its so tight. On 2021, the patient experienced every time put hands up don't have strength, very weak. On 2021, the patient experienced after i have vaccine in that spot the pain is there. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from until now its so tight, and every time put hands up don't have strength, very weak, and the outcome of after i have vaccine in that spot the pain is there was not reported. This report was non-serious.
3 boosters; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (3 boosters) and NO ADVERSE EVENT (No adverse event) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059A22A, 037F21A, 022M20A, 019B21A and 022M20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Nov-2021, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jul-2022, received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (3 boosters) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (3 boosters) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (3 boosters).    Concomitant medications were not reported.  On 28-Feb-2021 patient had received 1st dose of vaccine with lot number 022M20A. On 31-Mar-2021 patient had received 2nd dose of vaccine with lot number 019B21A, On 08-Aug-2021 patient had received 3rd dose of vaccine with lot number 022M20A. On 06-Nov-2021 patient had received 4th dose of vaccine with lot number 037F21A. On -14-Jul-2022 patient had received 5th dose of vaccine with lot number 059A22A.  Patient was not  immunocompromised. No treatment information was provided by the reporter
RED SWOLLEN PATCHES DIAGNOSED IN ER AS HIVES, TREATED WITH BENADRYL AND STEROIDS. RETURNED TO ER 11/17/2015 FOR SWOLLEN FEET AGAIN DIAGNOSED AS HIVES.
Pt presented to ER post ground level fall. He also was positive for COVID and reported that he has had a runny nose and congested for about a week and was exposed to his brother who was positive for COVID.
I had the regular symptoms such as a headache, sore arm, feeling tired. Two days later, I felt like I was going to faint and my heart felt very weak. It almost felt like my heart was fluttering. The main problem felt like I was going to faint and my blood pressure was dropping. My heart medications do make my blood pressure drop, but I wasn't sure what was going on. I felt very weak and thought I was going to pass out. I didn't. I just noticed for the next 5 days, I was pretty weak and tired. I attributed that to probably the vaccine. The treatment that I deduced from all of this was because my blood pressure was lower than normal. That's when I contacted the cardiologist and he took me off the spironolactone. I'm not sure if the doctor had taken into consideration that I also recently had my vaccine. Down the road, I had my heart failure retested and had my medications adjusted to higher doses and I'm not sure if the vaccine has a part in this. I'm unsure and there's too many variables. I'm unsure at this time of the cause.
Severe shortness of breath and wheezing had to use son's Albuterol inhaler. -Used one dose and then fully recovered.
Patient, a 15-year-old white, non-Hispanic male received his first Pfizer vaccine on 6/23/21 at 3:10pm. After 13 minutes post-vaccination, patient passed out. Had a bit of wheezing, pale, cold, and clammy skin. Was conscious when pharmacist went out at 3:30pm. Called 911 for paramedics. Have patient drink cold water in the mean time and have legs elevated to help with blood flow. When paramedics came, vital signs were checked. O2 saturation is 98%, blood pressure is 96/60, and pulse is 88 bpm. Patient feels much better after 30-45 minutes, and was able to leave the store with mom without going to emergency room.
I had my vaccination in 09/21/2022. I had a cough on 03/06/2023. I had 1 appointment for chest x-ray on 03/07/2023 and I was prescribed 2 inhalers. I have an appointment with pulmonology on 03/24/2023. I was prescribed an antibiotic on 03/14/2023.
10 days after the booster, I experienced left ear pain and blockage, swollen inner ear, tinnitus, burning sensation on left side brain, ear itching, headache on left side, lightheadedness and one incidence of balance problem. . Soon after, the right ear had ear pain ,  blockage and tinnitus, but no other symptoms.  My hearing was tested in December 2022 and January 2023 and  there was a 20% reduction in hearing in my left year.  My right ear had full hearing.
no fever;erythema of rt upper arm, nausea, felt fuzzy in head 1st 24hr;
Fuzzy head, lack of concentration, dizziness, nausea, tinnitus, off balance fatigue, head full feeling, facial and head numbness, scalp itching, hair loss, weight gain, bloating, depression, anxiety
Vaccine was ordered by Physician in error. I gave vaccine as ordered. Too early for child to have Hep A.
Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Medium, Systemic: Hyperventilation-Severe, Systemic: Shakiness-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: epipen given. called 911. but the patient was ok before they get to the store after giving epipen.
Approximately 30 minutes after vaccination client complained of nausea, dizziness, and shakiness. Client stated later in the evening she began to experience visual hallucinations. Client stated symptoms subsided after about two days. Client stated she visited ith her health provider as a result of her reaction to the vaccine.
UNDERSIDE OF RIGHT ARM HAS EXTENSIVE RED DISCOLORATION THAT HAS SPREAD & IS WARM TO THE TOUCH
She started out with a rash on her side hips that started a few days after the vaccine. She has never had a rash like this before and we have not changed anything about her diet or daily habits. The rash has progressively gotten worse over the last 9 days and today being the worst. It has spread to her chest and her thigh where it originally started is a deep red rash. We have an appointment scheduled with the Dr to have her checked 11/21.
Anaphylactic reaction; A spontaneous report (United States) was received from a consumer who is a female patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced an anaphylactic reaction.  The patient's medical history included allergy to azithromycin (hives). Concomitant medications were not reported.  On 09 JAN 2021, the patient received her first of two planned doses of mRNA-1273 (Batch number: unknown) for the prophylaxis of COVID-19 infection.  On 09 JAN 2021, while sitting in the waiting area, 8 to 10 minutes after the injection, the patient experienced warm feeling, tongue getting bigger and collapsed. She was given intravenous medications and health care professionals were monitoring her vitals. The patient was transported to emergency via ambulance and was given two doses of EpiPen in the ambulance and by the time she arrived hospital she was doing better and was discharged after 4 hours.  Treatment provided included EpiPen and intravenous medications.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of event anaphylactic reaction was unknown.; Reporter's Comments: This case concerns a female patient of unknown age with relevant medical history of allergy to azithromycin who  received her first of two planned doses of mRNA-1273 (Batch number: unknown) for the prophylaxis of COVID-19 infection and experienced a serious medically significant unlisted event of an anaphylactic reaction within 8-10 minutes after the injection. The reaction was described as warm feeling, tongue getting bigger and collapsed. Patient was transported to ER and given two doses of EpiPen while in the ambulance.  By the time she arrived at the hospital, she was doing better and was discharged after 4 hours. Treatment also included IV medications. Based on temporal association between the use of the product and the start date of the event within 8-10 minutes after the vaccine administration, a causal relationship cannot be excluded and the event of anaphylaxis reaction is possibly related.
Severe headaches, chills, Pain with joints, muscles. Left side of my body with swelling and weakness. Nausea and vomiting.
she came down; This case was reported by a consumer via and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient got the shingles vaccine and came down with it almost immediately. The follow-up would not possible as no contact details were available.
Several minutes after receiving the vaccine, the patient reported an unpleasant metallic taste in her mouth. The taste remained throughout her 30 min observation period. She called back the following day to report the taste was still present.
nausea without emesis;  drank water; emotional support:  fresh air symptoms resolved within 3 -5 mins.   Let lot after 10 mins of first report of symptom.  Has n/o cancer w/ chemo TX.
Initial unsolicited case received from non healthcare professional (consumer) on 04-Dec-2015. This case was linked to 2015SA206294 and 2015SA206306 (same reporter and same vaccine). This case involves a female patient (age was not reported) who was vaccinated with a dose of Meningococcal vaccine (manufacturer: unknown, dose, route and site of administration were not reported) on an unspecified date. Medical history and concomitant medications were not reported. On an unspecified date, after vaccination patient had experienced encephalitis and then died. Lab tests and corrective treatments were not reported. The outcome of the event was fatal. Documents held by Sender: none.
I was extremely sick, unable to get out of bed, chills, aches, pains, no energy.  Injection site extremely painful
Crying uncontrolablly and acting irrational. Was very upset and saying things that did not make sense.
Dizziness and a dull headache, I had a temperature of 99 when the ambulance got here. I called EMS because I was dizzy and the papers say to call EMS if I experience dizziness. They checked me out and said I didn't need to go to the ER.
Pt stated that she has a rash that developed the night of her vaccination. The rash covers her chest and upper stomach .
Patient reported pre-medicating with 50mg benadryl prior to vaccination due to history of anaphylaxis with Simponi. Patient received first dose Moderna vaccination then reported to observation area. Within minutes of arriving, she reported increased heart rate and pressure in her chest. She lied down and EMS was activated. Patient refused EMS transport to ER. 10 minutes after EMS left the scene, patient reported a worsening of symptoms. EMS was activated and patient was transported to ER.
Tiredness; Muscle pain; Chills; Fever; Joint pain; Vomiting; Nausea; Feeling unwell; This is a spontaneous report from a contactable nurse, the patient.  A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EH9899), intramuscular in the right arm on 16Dec2020 at 09:30 AM (at the age of 54-year-old) as a single dose for COVID-19 immunization. Medical history included hypertension, sleep apnoea syndrome, glucose tolerance impaired, breast cancer (5 years ago), and anxiety. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included HCTZ, losartan, anastrozole (ARIMIDEX), escitalopram oxalate (LEXAPRO), calcium, ergocalciferol (VITAMIN D), and fish oil; all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took Bactrim and experienced drug hypersensitivity. On 17Dec2020, at 10:00 AM, the patient experienced tiredness, muscle pain, chills, fever, joint pain, vomiting, nausea, feeling unwell. The events were reported as non-serious. The patient did not receive any treatment for the tiredness, muscle pain, chills, fever, joint pain, vomiting, nausea, and feeling unwell. The clinical outcome of the events tiredness, muscle pain, chills, fever, joint pain, vomiting, nausea, feeling unwell was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
1. Arm muscle very sore to date. 2. 10 days after the shot, tennis ball rash appeared on shoulder at the injection site. Very inchy, skin felt like leather, loss of feeling on rash site, lasted 5 days.
Pt developed a rash below the vaccine administration site.  The rash continued to spread down the arm. Pt went to prescriber where she was given a steroid medication.
Got another dose 4/18/2023; 1st dose 4/24/2022, 2nd on 4/14/2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 52-year-old male patient who received Herpes zoster (Shingrix) (batch number YC5Y7, expiry date 25-OCT-2024) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) (batch number YA29D, expiry date 06-OCT-2023) for prophylaxis.   Previously administered products included SHINGRIX (received the 1st dose last year on 24th April 2022).   On 18-APR-2023, the patient received the 3rd dose of Shingrix. On 14-APR-2023, the patient received the 2nd dose of Shingrix. On 14-APR-2023, not applicable after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: 1st dose 4/24/2022, 2nd on 4/14/2023). On 18-APR-2023, the patient experienced extra dose administered (Verbatim: Got another dose 4/18/2023). The outcome of the drug dose administration interval too long and extra dose administered were unknown.   Additional Information: GSK receipt date:19-APR-2023 The pharmacist did not had expiration date for second dose but had verified it with the batch identifier. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via postal. The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccine schedule. The patient received 3rd dose of Shingrix, which led to extra dose administered.
Information has been received from an 80 year old female with blood pressure and thyroid problems, allergy to penicillin and "betadine" and "problems with hormones", who 1.5 years ago, in approximately March 2007, was vaccinated with ZOSTAVAX (Oka/Merck) 0.65 ml, subcutaneously.  Concomitant therapy included "blood pressure medicine" and "thyroid medicine".  The patient reported that 3 weeks ago (on approximately 19-AUG-2008) she developed shingles on her waist and back on her left side, she also was experiencing "itchiness" and pain.  At the time of reporting the patient had not recovered.  The patient sought medical attention.  Additional information has been requested.
Redness spreading approximately 4 inches across arm, pain everywhere it is red, hot to the touch.
pt did not wait for 15 minutes in the observation area. She went to buy groceries and when in cashier line she felt faint. she sat down, paramedics were called.  The paramedics said she was alright and she left on her own. On follow up she says she has dizzy spells sometimes due to an irregular heartbeat. She said she was all better by the evening.
Body aches; Headache; Chills; Tiredness; Swollen lymph nodes; Overall unwell feeling; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the right arm on 19Apr2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 29Mar2021 (at the age of 60-year-old) as a single dose for COVID-19immunisation. On 19Apr2021 at 21:00, the patient experienced headache, body aches, chills, tiredness, swollen lymph nodes and overall unwell feeling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, body aches, chills, tiredness, swollen lymph nodes and overall unwell feeling were resolving at the time of the report.  No follow-up attempts are needed. No further information is expected.
DPT/MMR given in right arm, IPV in left arm. (04/05/2005) developed swelling on right upper arm that night- Next day seen in office. Entire upper arm with swelling, redness, warmth of upper right arm. RX Augmentin 200mg Q 12 H with food, and elevation. Never ran fever, never appeared ill, much better by 04/09/2005.
Woke up with extreme dizziness; everything spinning so rapidly; making her heave; nausea; soreness at injection site; fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Mar2021 15:30 (Lot number: EN-6206) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "known allergies" (unspecified if ongoing). Concomitant medication(s) included: LEVALBUTEROL [LEVOSALBUTAMOL]. Vaccination history included: Bnt162b2 (DOSE 1, Lot number: EN6200, Administration time: 04:15 PM. Vaccine location: Left arm), administration date: 19Feb2021, when the patient was 37 years old, for COVID-19 immunisation, reaction(s): "soreness at injection site", "period of inexplicable clumsiness". The following information was reported: DIZZINESS (non-serious) with onset 14Mar2021 08:45, outcome "unknown", described as "Woke up with extreme dizziness"; VERTIGO (non-serious) with onset 14Mar2021 08:45, outcome "unknown", described as "everything spinning so rapidly"; VOMITING (non-serious) with onset 14Mar2021 08:45, outcome "unknown", described as "making her heave"; NAUSEA (non-serious) with onset 14Mar2021 08:45, outcome "unknown", described as "nausea"; VACCINATION SITE PAIN (non-serious) with onset 14Mar2021 08:45, outcome "unknown", described as "soreness at injection site"; FATIGUE (non-serious) with onset 14Mar2021 08:45, outcome "unknown", described as "fatigue". Therapeutic measures were not taken as a result of dizziness, vertigo, vomiting, nausea, vaccination site pain, fatigue.  Additional information: The dizziness was the most intense she has ever experienced with everything spinning so rapidly. The dizziness is now mild when she is laying down, but she is unable to be upright without it returning and making her heave.  No follow-up attempts are possible. No further information is expected.
Patient came today in pharmacy to report a reaction, the injection site was red and the redness at the injection site was spreading for up to the left inside area of the left arm (about the size of a palm) and it was warm to touch and patient was suggested to apply cold compress.
Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: Abdominal Pain-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Diarrhea-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Joint Pain-Medium, Systemic: Nausea-Mild, Systemic: Shakiness-Mild, Systemic: Vomiting-Medium, Additional Details: nausea, vomiting and diarrhea lasted about 2 days, rash at injection site and fatigue present at 14 days post injection.
1 day p/vax pt started crying & screaming till 7PM; would not eat during the time; the next day just layed around was not self;